Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) vs Immunovant Inc. Common Stock (IMVT) Price & Performance

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)Trade
Immunovant Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs Immunovant Inc. Common Stock — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.26 (market cap $39.95B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 6× Immunovant Inc. Common Stock's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.2% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.

HLNIMVT
Market Cap
$39.95B$6.62B
Volume
18,243,5811,131,364
Sector
HealthHealth
52-Week High
$11.27$44.96
52-Week Low
$8.70$17.03
Typical Hold Time
0 Days0 Days
Enterprise Value
$49.77B$5.72B
Dividend Yield
2.2%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HLN
100% Buy0% Sell
Avg holding period · 0 Days
IMVT
100% Buy0% Sell
Avg holding period · 0 Days

About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.

Read more on HLN →

About Immunovant Inc. Common Stock

Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.

Read more on IMVT →